MEASUREMENT OF BENZODIAZEPINE RECEPTOR NUMBER AND AFFINITY IN HUMANS USING TRACER KINETIC MODELING, POSITRON EMISSION TOMOGRAPHY, AND [C-11] FLUMAZENIL

被引:77
作者
PRICE, JC
MAYBERG, HS
DANNALS, RF
WILSON, AA
RAVERT, HT
SADZOT, B
RATTNER, Z
KIMBALL, A
FELDMAN, MA
FROST, JJ
机构
[1] JOHNS HOPKINS MED INST,DEPT BIOSTAT,BALTIMORE,MD 21205
[2] JOHNS HOPKINS MED INST,DEPT ANESTHESIOL,BALTIMORE,MD 21205
[3] JOHNS HOPKINS MED INST,DEPT RADIOL,DIV NUCL MED,BALTIMORE,MD 21205
[4] JOHNS HOPKINS MED INST,DEPT ENVIRONM HLTH SCI,DIV RADIAT HLTH SCI,BALTIMORE,MD 21205
关键词
BENZODIAZEPINE RECEPTORS; C-11]FLUMAZENIL; HUMAN BRAIN; KINETIC MODELING; POSITRON EMISSION TOMOGRAPHY;
D O I
10.1038/jcbfm.1993.84
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Kinetic methods were used to obtain regional estimates of benzodiazepine receptor concentration (B(max)) and equilibrium dissociation constant (K(d)) from high and low specific activity (SA) [C-11]flumazenil ([C-11] Ro 15-1788) positron emission tomography studies of five normal volunteers. The high and low SA data were simultaneously fit to linear and nonlinear three-compartment models, respectively. An additional inhibition study (pretreatment with 0.15 mg/kg of flumazenil) was performed on one of the volunteers, which resulted in an average gray matter K1/k2 estimate of 0.68 +/- 0.08 ml/ml (linear three-compartment model, nine brain regions). The free fraction of flumazenil in plasma (f1) was determined for each study (high SA f1: 0.50 +/- 0.03; low SA f1: 0.48 +/- 0.05). The free fraction in brain (f2) was calculated using the inhibition K1/k2 ratio and each volunteer's mean f1 value (f2 across volunteers = 0.72 +/- 0.03 ml/ml). Three methods (Methods I-III) were examined. Method I determined five kinetic parameters simultaneously [K1, k2, k3 (= k(on)f2B(max)), k4, and k(on)f2/SA] with no a priori constraints. An average k(on) value of 0.030 +/- 0.003 nM-1 min-1 was estimated for receptor-rich regions using Method I. In Methods II and III, the k(on)f2/SA parameter was specifically constrained using the Method I value of k(on) and the volunteer's values of f2 and low SA (Ci/mumol). Four parameters were determined simultaneously using Method II. In Method III, K1/k2 was fixed to the inhibition value and only three parameters were estimated. Method I provided the most variable results and convergence problems for regions with low receptor binding. Method II provided results that were less variable but very similar to the Method I results, without convergence problems. However, the K1/k2 ratios obtained by Method II ranged from 1.07 in the occipital cortex to 0.61 in the thalamus. Fixing the K1/k2 ratio in Method III provided a method that was physiologically consistent with the fixed value of f2 and resulted in parameters with considerably lower variability. The average B(max) values obtained using Method III were 100 +/- 25 nM in the occipital cortex, 64 +/- 18 nM in the cerebellum, and 38 +/- 5.5 nM in the thalamus; the average K(d) was 8.9 +/- 1.0 nM (five brain regions).
引用
收藏
页码:656 / 667
页数:12
相关论文
共 44 条
  • [1] CENTRAL BENZODIAZEPINE RECEPTORS IN HUMAN BRAIN - ESTIMATION OF REGIONAL B(MAX) AND K(D) VALUES WITH POSITRON EMISSION TOMOGRAPHY
    ABADIE, P
    BARON, JC
    BISSERBE, JC
    BOULENGER, JP
    RIOUX, P
    TRAVERE, JM
    BARRE, L
    PETITTABOUE, MC
    ZARIFIAN, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (01) : 107 - 115
  • [2] ALTMAN PL, 1961, BLOOD OTHER BODY FLU, P19
  • [3] Bevington P.R., 1969, DATA REDUCTION ERROR
  • [4] MAPS OF RECEPTOR-BINDING PARAMETERS IN THE HUMAN BRAIN - A KINETIC-ANALYSIS OF PET MEASUREMENTS
    BLOMQVIST, G
    PAULI, S
    FARDE, L
    ERIKSSON, L
    PERSSON, A
    HALLDIN, C
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 16 (4-6): : 257 - 265
  • [5] VISUALIZATION OF FLUNITRAZEPAM-C-11 DISPLACEMENT IN THE BRAIN OF THE LIVE BABOON
    COMAR, D
    MAZIERE, M
    GODOT, JM
    BERGER, G
    SOUSSALINE, F
    MENINI, C
    ARFEL, G
    NAQUET, R
    [J]. NATURE, 1979, 280 (5720) : 329 - 331
  • [6] THE KINETICS AND DISPLACEMENT OF [FLUNITRAZEPAM-C-11 IN THE BRAIN OF THE LIVING BABOON
    COMAR, D
    MAZIERE, M
    CEPEDA, C
    GODOT, JM
    MENINI, C
    NAQUET, R
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 75 (01) : 21 - 26
  • [7] DANNALS RF, 1990, APPL RADIAT ISOTOPES, V41, P541
  • [8] DANNALS RF, 1986, APPL RADIAT ISOTOPES, V37, P433
  • [9] ABSENCE OF CENTRAL EFFECTS IN MAN OF THE BENZODIAZEPINE ANTAGONIST RO-15-1788
    DARRAGH, A
    LAMBE, R
    OBOYLE, C
    KENNY, M
    BRICK, I
    [J]. PSYCHOPHARMACOLOGY, 1983, 80 (02) : 192 - 195
  • [10] PLASMA PHARMACOKINETICS AND METABOLISM OF THE BENZODIAZEPINE ANTAGONIST [C-11] RO 15-1788 (FLUMAZENIL) IN BABOON AND HUMAN DURING POSITRON EMISSION TOMOGRAPHY STUDIES
    DEBRUYNE, D
    ABADIE, P
    BARRE, L
    ALBESSARD, F
    MOULIN, M
    ZARIFIAN, E
    BARON, JC
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1991, 16 (02) : 141 - 152